Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jason A Gluck"'
600. Cefiderocol is Not Sequestered in an Ex vivo Extracorporeal Membrane Oxygenation (ECMO) Circuit
Publikováno v:
Open Forum Infectious Diseases. 9
Background ECMO is widely used in critically-ill patients that require respiratory and/or cardiac support, but may affect drug exposure by altering pharmacokinetics within patients or sequestering drugs in the circuit. Cefiderocol, a siderophore anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09016f64a366462c279bbbbea605d04f
https://doi.org/10.1093/ofid/ofac492.652
https://doi.org/10.1093/ofid/ofac492.652
Publikováno v:
International Journal of Antimicrobial Agents. 60:106603
This study determined the pharmacokinetics of cefepime in patients requiring extracorporeal membrane oxygenation (ECMO) support to guide dosage selection. Cefepime population pharmacokinetics where characterized in Pmetrics for R for six critically i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c575282ea304866f588d6045ff851638
https://doi.org/10.1016/j.ijantimicag.2022.106603
https://doi.org/10.1016/j.ijantimicag.2022.106603
Publikováno v:
Circulation. 138
Introduction: Extracorporeal cardiopulmonary resuscitation (ECPR) may be considered for select cardiac arrest patients for whom the suspected etiology of the arrest is potentially reversible. In adults, the survival to discharge with ECPR is reported
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a421ead42bfdce192142636dd1e200a
https://doi.org/10.1161/circ.138.suppl_1.17412
https://doi.org/10.1161/circ.138.suppl_1.17412
Publikováno v:
ESC Heart Failure
Aims Heart failure (HF) and diabetes mellitus (DM) often coexist and have bidirectional association. Advanced HF is associated with worsened glycaemic control. This meta‐analysis investigated the effects of left ventricular assist device (LVAD) imp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dfa6c30ff2744487825f941e2a984c4b
https://pubmed.ncbi.nlm.nih.gov/30052326
https://pubmed.ncbi.nlm.nih.gov/30052326
Publikováno v:
Connecticut medicine. 79(8)
Enlargement of the left atrium is a marker of mortality in the general population. Left atrial volume index (LAVI) has long been proposed as a measure of prognosis in patients with heart failure (HF). The aim of this meta-analysis was to assess the u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a767d9333cc31f99e99f7d4db06c971c
https://pubmed.ncbi.nlm.nih.gov/26506678
https://pubmed.ncbi.nlm.nih.gov/26506678
Publikováno v:
Connecticut medicine. 79(1)
While advancements in ventricular assist device (VAD) therapy have improved survival and quality of life for select patients with advanced heart failure (HF), variations in provider knowledge and opinions may ultimately serve as barriers to therapy.A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c102b94de2f6059cc1f42907be43c450
https://pubmed.ncbi.nlm.nih.gov/26244190
https://pubmed.ncbi.nlm.nih.gov/26244190
Autor:
Adam M, Noyes, Jason A, Gluck, Daniel, Madison, Bernadette, Madison, Theodore, Madison, Craig I, Coleman, Jeffery, Mather, Jeffery, Kluger
Publikováno v:
Connecticut medicine. 79(1)
To determine whether a novel, service-centric, medical emergency team (MET) model can impact cardiac arrest (CA) rates.A retrospective pre- vs. postintervention analysis was performed on patients ≥ 18 years who had a CA between 2007 and 2012. A ser
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c9d364a954d675db72afd84c86f639e6
https://pubmed.ncbi.nlm.nih.gov/26244191
https://pubmed.ncbi.nlm.nih.gov/26244191
Publikováno v:
Artificial organs. 40(2)
Our aim was to identify relevant literature supporting the use of phosphodiesterase-5 (PDE5) inhibitors in patients with persistent pulmonary hypertension with signs of postprocedural right ventricular (RV) dysfunction following left ventricular assi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::70e019e0bb4da1116b60ec45a4f37a9f
https://pubmed.ncbi.nlm.nih.gov/26043796
https://pubmed.ncbi.nlm.nih.gov/26043796
Autor:
Indrajit Choudhuri, Rozalia Tverskaya, Galina Kazanikova, Jason A Gluck, Seth I Keller, Ranjit Suri
Publikováno v:
Circulation. 116
Background: A “cooling off” period (COP) of 40 days after MI and 90 days after coronary revascularization or non-ischemic CM (NICM) diagnosis is customary to allow clinical improvement prior to assessing the need for ICD implantation. The COP cre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7277f1cdf1ed6381c51b90079d7326b
https://doi.org/10.1161/circ.116.suppl_16.ii_348-c
https://doi.org/10.1161/circ.116.suppl_16.ii_348-c